Patient and aneurysm characteristics | |||||||||||
Patient No | Aneurysm location* (ICA) | Transverse diameter (mm) | Height (mm) | Stent | Localization of ISS† | Inadequate apposition | Previous treatment | RROC STFU | RROC LTFU | Stenosis STFU (%) | Stenosis LTFU (%) |
1 | C4 | 3.6 | 3.4 | FR | Proximal | 1 | 1 | 20 | 17 | ||
2 | C7 | 4.8 | 4.4 | FR | Distal | 1 | 1 | 43 | 12 | ||
3 | C6 | 3.7 | 3.5 | FR | Proximal | 3 | 3 | 21 | 8 | ||
4 | C6 | 4.2 | 4 | FR | Mid | 1 | 1 | 31 | 27 | ||
5 | C6 | 2.2 | 3.2 | FR | Mid | 3 | 2 | 29 | 6 | ||
6 | C6 | 2 | 2 | DR | Mid | Yes | 1 | 1 | 25 | 19 | |
7 | C6 | 4.1 | 3.2 | PF | Mid | Coils | 1 | 1 | 23 | 8 | |
8 | C6 | 2.7 | 3.1 | PF | Mid | 1 | 1 | 36 | 4 | ||
9 | C6 | 4.8 | 8.7 | PF | Mid | 2 | 1 | 29 | 4 | ||
10 | C5 | 10.3 | 16.2 | FR | Mid | 3 | 2 | 10 | 2 | ||
11 | C6 | 2.7 | 2.5 | PF | Mid | Coils | 3 | 1 | 46 | 3 | |
12 | C6 | 6 | 9 | DR | Mid | 1 | 1 | 28 | 0 | ||
13 | C6 | 3.8 | 3.3 | PF | Mid | 1 | 1 | 58 | 26 | ||
14 | C6 | 4.2 | 3.9 | PF | Distal | 1 | 1 | 49 | 22 | ||
15 | C7 | 3.3 | 4.3 | DR | Mid | 1 | 1 | 12 | 4 | ||
16 | C6 | 3.4 | 4.5 | DR | Mid | 1 | 1 | 43 | 28 | ||
17 | C6 | 3.1 | 3.5 | DR | Proximal | 2 | 1 | 15 | 15 | ||
18 | C7 | 4 | 4.3 | DR | Mid | 1 | 1 | 37 | 21 |
*According to the Bouthillier classification.
†In relation to the stent.
DR, Derivo (Acandis, Germany); FR, FRED (MicroVention, USA); ICA, internal carotid artery; ISS, in-stent stenosis; LTFU, long term follow-up; PF, Pipline Flex (Medtronic, USA); RROC, Raymond–Roy Occlusion Rate; STFU, short term follow-up.